Skip to content

Effects of high beta-glucan barley rice on visceral fat obesity in Japanese subjects. A randomized double blind placebo-controlled study

Effects of high beta-glucan barley rice on visceral fat obesity in Japanese subjects. A randomized double blind placebo-controlled study - Effects of high beta-glucan barley rice on visceral fat obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014793
Enrollment
100
Registered
2014-08-08
Start date
2014-08-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

visceral fat obesity

Interventions

intake of 200 grams of high beta-glucan barley rice twice daily for 12 weeks intake of 200 grams of barley rice without beta-glucan twice daily for 12 weeks

Sponsors

Osaka city University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) age between 30 and 70 years old at consent 2) waist circumference >=85 cm (man), >=90 cm (woman) 3) subjects understand the study procedures and agree to participate in the study by giving informed consent prior to the study.

Exclusion criteria

Exclusion criteria: 1) experienced body weight changes >= 10% within a year before the start date of this study 2) attended another clinical study within a month before the start date of this study 3) Fasting blood sugar >=126 mg/dl or HbA1c (NGSP) >=6.5% or diabetic patient 4) has history of serious cardiovascular diseases 5) has history of surgery in gastrointestinal tract 6) takes drugs to treat dyslipidemia 7) has continuous intake of dietary fiber supplement or beta glucan (barley, mushroom, black yeast, etc) 8) has continuous intake of Divaricate Saposhnikovia Miraculous Powder 9) has serious liver or kidney disease 10) has history of malignant diseases 11) has serious infectious diseases 12) pregnant or lactating woman 13) allergic to raw materials 14) is not appropriate in the investigator's opinion

Design outcomes

Primary

MeasureTime frame
change in visceral fat area

Secondary

MeasureTime frame
1) body weight, waist circumference, subcutaneous fat area, total fat area 2) total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol 3) HbA1c, insulin, free fatty acid, fasting blood sugar 4) leptin, adiponectin 5) blood pressure 6) questionnaire survey about eating behavior and psychosomatic state

Countries

Japan

Contacts

Public ContactHisako Fujii

Osaka city University Hospital Center for Drug & Food Clinical Evaluation

hfujii@med.osaka-cu.ac.jp06-6645-3443

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026